We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Benign Hematology

Journal Scan / Research · February 26, 2019

Eculizumab in Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome

British Journal of Haematology

 

Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Haematology
Eculizumab in Paroxysmal Nocturnal Haemoglobinuria and Atypical Haemolytic Uraemic Syndrome: 10-Year Pharmacovigilance Analysis
Br. J. Haematol 2019 Feb 15;[EPub Ahead of Print], G Socié, MP Caby-Tosi, JL Marantz, A Cole, CL Bedrosian, C Gasteyger, A Mujeebuddin, P Hillmen, J Vande Walle, H Haller

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading